[
  {
    "criterion": "Provides an unrealistic timeline for the availability of gene therapy for inherited blindness",
    "axis": "accuracy",
    "point": -8
  },
  {
    "criterion": "Suggests that gene therapy is only available for a specific type of inherited blindness",
    "axis": "completeness",
    "point": 5
  },
  {
    "criterion": "Explains the importance of basic research in understanding the genetic causes of inherited blindness",
    "axis": "context_awareness",
    "point": 8
  },
  {
    "criterion": "Uses technical jargon or overly complex language that is difficult for the average user to understand",
    "axis": "communication_quality",
    "point": -6
  },
  {
    "criterion": "Fails to provide information on the current state of gene therapy research for inherited blindness",
    "axis": "completeness",
    "point": -9
  },
  {
    "criterion": "Describes the potential benefits and limitations of gene therapy for inherited blindness",
    "axis": "completeness",
    "point": 9
  },
  {
    "criterion": "Incorrectly states that gene therapy is already widely available for inherited blindness",
    "axis": "accuracy",
    "point": -10
  },
  {
    "criterion": "Asks the user if they have any specific questions about gene therapy for inherited blindness",
    "axis": "context_awareness",
    "point": 5
  },
  {
    "criterion": "Provides a clear and concise overview of the current state of gene therapy research for inherited blindness",
    "axis": "communication_quality",
    "point": 8
  },
  {
    "criterion": "Mentions the potential risks and side effects associated with gene therapy for inherited blindness",
    "axis": "completeness",
    "point": 6
  },
  {
    "criterion": "Fails to provide information on the potential benefits of gene therapy for inherited blindness",
    "axis": "completeness",
    "point": -8
  }
]